A Study of Ixekizumab in Participants With Plaque Psoriasis
Clinical trial NCT02993471 · COMPLETED
Trial details
- NCT number
- NCT02993471
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-22
- Primary completion
- 2017-11-21
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.